TCS launches agentic AI platform for drug development and clinical trials
TCS has launched an agentic AI platform to transform drug development and, under the name AgentHub, is bringing AI workers into clinical trials. The company is building the platform in India to speed up drug discovery and trials.
Who is affected and how
- pharmaceuticals
- Agentic automation options should be mapped with trial sponsors and CRO partners.
Sources
- TCS launches Agentic AI platform to transform drug developmenttata consultancy services · Aug 17, 2026
- TCS Launches AgentHub to Scale Agentic AI Across Drug Development and Pharmacovigilance - MedPath Trialtrial.medpath.com · Aug 17, 2026
- TCS ADD AgentHub Brings Agentic AI to Drug Developmenttheoutpost.ai · Aug 17, 2026
- TCS launches Agentic AI platform to transform drug development - scanx.tradescanx.trade · Aug 17, 2026
- TCS building AI platform to accelerate drug discovery, clinical trials in Indiaindia today · Aug 17, 2026
- TCS building AI platform to accelerate drug discovery, clinical trials in India - India Todayindiatoday.in · Aug 17, 2026
- TCS Launch AgentHub to Bring AI Workers Into Pharma Clinical Trialsanalytics insight · Aug 17, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.